A 52-year-old woman with a 10-year history of rheumatoid arthritis presents with progressive joint destruction. Her serum shows elevated rheumatoid factor and anti-CCP antibodies. Which of the following is NOT a characteristic feature of the pathophysiology of rheumatoid arthritis?

Explanation

## Pathophysiology of Rheumatoid Arthritis ### Central Immune Mechanisms **Key Point:** Rheumatoid arthritis is a CD4+ T cell-driven autoimmune disease characterized by loss of tolerance to self-antigens, particularly citrullinated proteins. ### Role of T Cell Subsets | Cell Type | Role in RA | Evidence | |-----------|-----------|----------| | CD4+ T helper cells | Initiate and perpetuate immune response; activate B cells and macrophages | Primary driver; anti-TNF therapy effective | | CD8+ cytotoxic T cells | Minimal direct role in cartilage destruction | Not primary target of therapy | | B cells | Produce rheumatoid factor and anti-CCP antibodies | Key autoantibodies | | Macrophages/Fibroblasts | Produce TNF-α, IL-6, IL-8, MMPs | Drive inflammation and tissue damage | ### Key Pathologic Features 1. **Synovial Inflammation** - Infiltration by CD4+ T cells, B cells, and macrophages - Formation of lymphoid aggregates and germinal centers - Hyperplasia of synovial lining layer 2. **Cytokine Cascade** - TNF-α and IL-6 are central pro-inflammatory cytokines - IL-17 produced by Th17 cells amplifies inflammation - These drive osteoclast activation and bone resorption 3. **Immune Complex Formation** - Rheumatoid factor (IgM/IgG against Fc of IgG) forms complexes - Anti-CCP antibodies also participate in complex formation - Complexes activate complement via classical pathway - Complement deposition recruits more inflammatory cells 4. **Cartilage and Bone Destruction** - Synovial fibroblasts and macrophages produce matrix metalloproteinases (MMPs) - Osteoclasts activated by RANKL (produced by T cells and fibroblasts) - Pannus formation erodes cartilage from margins **High-Yield:** CD4+ T helper cells are the orchestrators of RA pathology, NOT CD8+ cytotoxic T lymphocytes. CD8+ cells play a minimal direct role in cartilage destruction. The disease is driven by CD4+ Th1 and Th17 responses. **Clinical Pearl:** The effectiveness of anti-TNF therapy and anti-IL-6 therapy confirms the central role of these cytokines, which are produced primarily by macrophages and fibroblasts, not by cytotoxic T cells. **Mnemonic:** **TIFF** — T helper (CD4+), Immune complexes, Fibroblasts/macrophages (TNF-α, IL-6), Fibroblasts (MMPs) drive RA pathology.